Skip to main content
. 2006 Jan 24;30(1):7–15. doi: 10.1016/j.jemermed.2005.03.011

Table 2.

Characteristics and Laboratory Findings in a Cluster of SARS Patients

HCWs (n = 4) Non-HCWs (n = 12) p Value
General data
 Age (years) 28.0 ± 1.4 47.8 ± 18.2 0.051
 Female/male 3/1 7/5 NS
Lymphopenia
 Peak (× 106/L) 299.8 ± 197.1 355.0 ± 249.8 NS
 On fever day 10.5 ± 3.3 10.3 ± 3.8 NS
Thrombocytopenia
 Peak (× 109/L) 157.8 ± 96.5 147.8 ± 54.8 NS
 On fever day 7.3 ± 1.9 7.8 ± 3.5 NS
Lactate dehydrogenase elevation
 Peak (U/L) 426.0 ± 335.2 434.9 ± 190.0 NS
 On fever day 10.3 ± 2.4 12.3 ± 3.7 NS
Creatine kinase elevation
 Peak (U/L) 140.3 ± 64.1 210.7 ± 130.2 NS
 On fever day 8.5 ± 1.3 9.2 ± 4.7 NS
Aspartate aminotransferase elevation
 Peak (U/L) 92.8 ± 79.9 79.5 ± 44.3 NS
 On fever day 13.3 ± 3.0 10.8 ± 4.4 NS
Alanine aminotransferase elevation
 Peak (U/L) 129.0 ± 94.9 107.8 ± 49.3 NS
 On fever day 14.8 ± 1.7 14.9 ± 4.6 NS
C-reactive protein elevation
 Peak (mg/Dl) 3.5 ± 4.0 11.0 ± 6.1 0.038
 On fever day 11.8 ± 1.3 11.9 ± 4.0 NS
Desaturation
 Peak (pO2/FiO2 ratio) 274.5 ± 58.6 167.6 ± 91.9 0.049
 On fever day 12.5 ± 3.1 11.9 ± 2.2 NS
Intubation and mortality
 Intubation 0/4 4/12 0.516
 Mortality 0/4 3/12 0.529

Data are presented as mean ± SD. NS = not significant.

On fever day indicates when the laboratory abnormalities peaked in relation to the number of days after the onset of documented fever > 38°C.